Novartis Inks Potential $1.3B Contract with Korean Biotech for Small Molecule

cafead

Administrator
Staff member
  • cafead   Nov 07, 2023 at 10:12: AM
via Novartis on Monday inked a technology export contract with Korean biotech company Chong Kun Dang Pharmaceutical for an early-stage HDAC6 Inhibitor, according to Korea Biomedical Review.

article source